Literature DB >> 34931320

Abstinence versus moderation recovery pathways following resolution of a substance use problem: Prevalence, predictors, and relationship to psychosocial well-being in a U.S. national sample.

David Eddie1, Brandon G Bergman1, Lauren A Hoffman1, John F Kelly1.   

Abstract

BACKGROUND: Many people who report resolving an alcohol or other drug (AOD) problem continue some level of substance use. Little information exists, however, regarding the prevalence of this resolution pathway, or how continued substance use after resolving an AOD problem, relative to abstinence, relates to functioning, quality of life, and happiness (i.e., well-being). Greater knowledge of the prevalence and correlates of non-abstinent AOD problem resolution could inform public health messaging and clinical guidelines, while encouraging substance use goals likely to maximize well-being and reduce risks.
METHODS: We analyzed data from a nationally representative sample of individuals who endorsed having resolved an AOD problem (N = 2002). Analyses examined: (1) The prevalence of various substance use statuses coded from lowest to highest risk: (a) continuous abstinence from all AOD since problem resolution; (b) current abstinence from all AOD with some use since problem resolution; (c) current use of a substance reported as a secondary substance; (d) current use of the individual's primary substance only; or, (e) current use of a secondary and primary substance; (2) relationships between substance use status and demographic, clinical, and service use history measures; and (3) the relationship between substance use status and well-being. Weighted, controlled, regression analyses examined the influence of independent variables on substance use status.
RESULTS: (1) Prevalence: In this sample, 20.3% of patients endorsed continuous abstinence; 33.7% endorsed current abstinence; 21.0% endorsed current use of a secondary substance; 16.2% endorsed current use of a primary substance; and 8.8% endorsed current use of both a secondary and a primary substance. (2) Correlates: Lower-risk substance use status was associated with the initiation of regular substance use at an older age, more years since problem resolution, and fewer lifetime psychiatric diagnoses. (3) Well-Being: Controlling for pertinent confounds, lower-risk substance use status was independently associated with greater self-esteem, happiness, quality of life and functioning, and recovery capital, as well as less psychological distress.
CONCLUSIONS: About half of Americans who self-identify as having resolved an AOD problem continue to use AOD in some form. It appears that, although for many abstinence is not necessary to overcome an AOD problem, it is likely to lead to better functioning and greater well-being. Further, people appear to gravitate toward abstinence/lower risk substance use with greater time since problem resolution.
© 2021 by the Research Society on Alcoholism.

Entities:  

Keywords:  abstinence versus continued substance use; alcohol and other drug problem resolution; primary and secondary substances; recovery capital; well-being

Mesh:

Year:  2022        PMID: 34931320      PMCID: PMC8858850          DOI: 10.1111/acer.14765

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  35 in total

1.  Long-term outcomes of alcohol use disorders: comparing untreated individuals with those in alcoholics anonymous and formal treatment.

Authors:  C Timko; R H Moos; J W Finney; M D Lesar
Journal:  J Stud Alcohol       Date:  2000-07

2.  Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition.

Authors:  Russell E Glasgow; Edward Lichtenstein; Alfred C Marcus
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

3.  Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes.

Authors: 
Journal:  J Stud Alcohol       Date:  1997-01

4.  Abstinence Not Required: Expanding the Definition of Recovery from Alcohol Use Disorder.

Authors:  Katie Witkiewitz; Jalie A Tucker
Journal:  Alcohol Clin Exp Res       Date:  2019-12-04       Impact factor: 3.455

5.  Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study.

Authors:  P Crits-Christoph; L Siqueland; J Blaine; A Frank; L Luborsky; L S Onken; L R Muenz; M E Thase; R D Weiss; D R Gastfriend; G E Woody; J P Barber; S F Butler; D Daley; I Salloum; S Bishop; L M Najavits; J Lis; D Mercer; M L Griffin; K Moras; A T Beck
Journal:  Arch Gen Psychiatry       Date:  1999-06

6.  Differences between abstinent and non-abstinent individuals in recovery from alcohol use disorders.

Authors:  Meenakshi Sabina Subbaraman; Jane Witbrodt
Journal:  Addict Behav       Date:  2014-07-15       Impact factor: 3.913

7.  Recovery from DSM-IV alcohol dependence: United States, 2001-2002.

Authors:  Deborah A Dawson; Bridget F Grant; Frederick S Stinson; Patricia S Chou; Boji Huang; W June Ruan
Journal:  Addiction       Date:  2005-03       Impact factor: 6.526

8.  Outpatient alcoholism treatment--24-month outcome and predictors of outcome.

Authors:  Michael Soyka; Peggy Schmidt
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-29

9.  Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy.

Authors:  John F Kelly; Brandon Bergman; Bettina B Hoeppner; Corrie Vilsaint; William L White
Journal:  Drug Alcohol Depend       Date:  2017-10-18       Impact factor: 4.492

10.  Recovery capital as prospective predictor of sustained recovery, life satisfaction, and stress among former poly-substance users.

Authors:  Alexandre B Laudet; William L White
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

View more
  1 in total

1.  The Holistic Recovery Capital in Gambling Disorder index: A pilot study.

Authors:  Belle Gavriel-Fried; Niva Lev-El; Shane W Kraus
Journal:  J Behav Addict       Date:  2022-06-29       Impact factor: 7.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.